NDC 0178-0513

Utira-C

Methenamine, Sodium Phosphate Monobasic, Phenyl Salicylate, Methylene Blue, Hyoscyamine Sulfate

Utira-C is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Mission Pharmacal Company. The primary component is Methenamine; Sodium Phosphate, Monobasic; Phenyl Salicylate; Methylene Blue; Hyoscyamine Sulfate.

• Product ID: 0178-0513_05e900d7-3b87-4166-b213-b9e26c65ff14
• NDC: 0178-0513
• Product Type: Human Prescription Drug
• Proprietary Name: Utira-C
• Generic Name: Methenamine, Sodium Phosphate Monobasic, Phenyl Salicylate, Methylene Blue, Hyoscyamine Sulfate
• Dosage Form: Tablet
• Route of Administration: ORAL
• Marketing Start Date: 2011-09-11
• Marketing Category: UNAPPROVED DRUG OTHER / UNAPPROVED DRUG OTHER
• Labeler Name: Mission Pharmacal Company
• Substance Name: METHENAMINE; SODIUM PHOSPHATE, MONOBASIC; PHENYL SALICYLATE; METHYLENE BLUE; HYOSCYAMINE SULFATE
• Active Ingredient Strength: 82 mg/1; mg/1; mg/1; mg/1; mg/1
• Pharm Classes: Oxidation-Reduction Activity [MoA],Oxidation-Reduction Agent [EPC]
• NDC Exclude Flag: E
• Listing Certified Through: 2017-12-31

Packaging

NDC 0178-0513-01

100 TABLET in 1 BOTTLE (0178-0513-01)

• Marketing Start Date: 2011-09-11
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 0178-0513-01 [00178051301]

Utira-C TABLET

• Marketing Category: unapproved drug other
• Product Type: HUMAN PRESCRIPTION DRUG
• Billing Unit: EA
• Marketing Start Date: 2011-09-11

Drug Details

Active Ingredients

Ingredient	Strength
METHENAMINE	81.6 mg/1

OpenFDA Data

• SPL SET ID: a39b46a2-f7e1-444f-b992-6f81b5e306ef
• Manufacturer:
  • Mission Pharmacal Company
• UNII:
  • 3980JIH2SW
  • J50OIX95QV
  • T42P99266K
  • 28A37T47QO
  • F2R8V82B84
• RxNorm Concept Unique ID - RxCUI:
  • 1047795
  • 1047786

Pharmacological Class

• Oxidation-Reduction Activity [MoA]
• Oxidation-Reduction Agent [EPC]